Publications by authors named "Peter LaCamera"

Claim this Profile
T
TRPC6 inhibitor (BI 764198) to reduce risk and severity of ARDS due to COVID-19: a phase II randomised controlled trial.
Lorraine B Ware, Nima Soleymanlou, Danny Francis McAuley, Vicente Estrada, George A Diaz, Peter Lacamera

Thorax· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Manifestations of Subjects With the Non-Specific Pulmonary Function Test Pattern.
James Tasch, Samer Abujaber, Laith Hattar, Aju Jose, Lori Lyn Price, Peter LaCamera

Open Respir Arch· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis.
Todd L Astor, Hilary J Goldberg, Laurie D Snyder, Andrew Courtwright, Ramsey Hachem, Peter LaCamera

Ther Adv Respir Dis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bronchial Thermoplasty in Patients With Severe Asthma at 5 Years: The Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma Study.
Geoffrey Chupp, Joel N Kline, Sumita B Khatri, Charlene McEvoy, Gerard A Silvestri, Peter LaCamera

Chest· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physician characteristics associated with treatment initiation patterns in idiopathic pulmonary fibrosis.
Peter P LaCamera, Susan L Limb, Tmirah Haselkorn, Elizabeth A Morgenthien, John L Stauffer

Chron Respir Dis· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Predictive Model for Acute Respiratory Distress Syndrome Mortality Using Red Cell Distribution Width.
Ala Alkhatib, Lori Lyn Price, Rania Esteitie, Peter LaCamera

Crit Care Res Pract· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1b Study of Vismodegib with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis.
Antje Prasse, Murali Ramaswamy, Shaun Mohan, Lin Pan, Andrew Kenwright, Peter P LaCamera

Pulm Ther· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between dexmedetomidine use for the treatment of alcohol withdrawal syndrome and intensive care unit length of stay.
Ekaterina R Yavarovich, Maythawee Bintvihok, Justin C McCarty, Janis L Breeze, Peter LaCamera

J Intensive Care· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serious adverse events in patients with idiopathic pulmonary fibrosis in the placebo arms of 6 clinical trials.
Wim Wuyts, Danielle Antin-Ozerkis, J Terrill Huggins, Peter P LaCamera, Paolo Spagnolo

Respir Med· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary edema during the Boston Marathon.
Joe Aoun, Khabib Dgayli, Cynthia Abou Zeid, Gordon Wong, Peter LaCamera

Respir Med Case Rep· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Practice Patterns for Prevention and Management of Potential Adverse Events with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis.
Mark L Wencel, Tmirah Haselkorn, Susan L Limb, John L Stauffer, Elizabeth Morgenthien, Peter P LaCamera

Pulm Ther· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Delayed Admission to the Intensive Care Unit from the Emergency Department upon Sepsis Outcomes and Sepsis Protocol Compliance.
Michael Agustin, Lori Lyn Price, Augustine Andoh-Duku, Peter LaCamera

Crit Care Res Pract· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak.
Andrew M Tager, Peter LaCamera, Barry S Shea, Gabriele S Campanella, Moisés Selman

Nat Med· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10.
Andrew M Tager, Richard L Kradin, Peter LaCamera, Scott D Bercury, Gabriele S V Campanella

Am J Respir Cell Mol Biol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing plasmalogen levels protects human endothelial cells during hypoxia.
Raphael A Zoeller, Todd J Grazia, Peter LaCamera, James Park, Daniel P Gaposchkin

Am J Physiol Heart Circ Physiol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis